NCT00104065View on ClinicalTrials.gov

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Stomatitis
Interventions
DRUG

CG53135-05, velafermin

Trial Locations (9)

10021

Research Facility, New York

27157

Research Facility, Winston-Salem

33136

Research Facility, Miami

44195

Research Facility, Cleveland

60611

Research Facility, Chicago

80218

Research Facility, Denver

92037

Research Facility, La Jolla

97239

Research Facility, Portland

01655

Research Facility, Worcester

Sponsors
All Listed Sponsors
lead

CuraGen Corporation

INDUSTRY